STEP 1 (published in NEJM 2021) demonstrated that participants receiving semaglutide 2.4 mg experienced mean reductions in total cholesterol of approximately 5-7%, LDL-C reductions of 5-8%, and triglyceride reductions of 12-15% from baseline
Daily totals: 105 grams protein, 29 grams fiber, 1,220 calories
It is the maximum approved strength of subcutaneous GLP-1 receptor agonist injection, used as a weekly maintenance dose to sustain long-term weight reduction and permanent obesity control under medical supervision
Wegovy is also a GLP-1 that acts as a natural hormone in your body to tell your brain to regulate your appetite, therefore, helping you feel fuller faster to manage your weight
Weekly drugs remove the daily decision, which can help people with irregular schedules stick with their treatment